Wang, Yujing, et al. “Suppression of Epidermal Growth Factor Receptor by Erlotinib Attenuates Carvacrol-Induced Skin Inflammation”. Acta Dermato-Venereologica, vol. 104, Dec. 2024, p. adv40975, doi:10.2340/actadv.v104.40975.